CDK1 and hepatocellular carcinoma: For example, as CDK1 is known to be enriched in many cancer types, including breast cancer [120], pancreatic ductal adenocarcinoma [121], oral squamous cell carcinoma [122], and hepatocellular carcinoma [123], consideration of CDK1 as a potential biomarker may be advisable.